N-terminal acetylation and C-terminal amidation: terminal modifications and how they are verified

A linear synthetic peptide has two chemically distinct ends: a free alpha-amine at the N-terminus and a free carboxylic acid at the C-terminus. Many research peptides do not carry these groups in their native form. The N-terminus is frequently acetylated, the C-terminus is frequently converted to a primary amide, and some sequences carry both caps. These changes are small in terms of molecular weight, yet they alter net charge, hydrophobicity, susceptibility to exopeptidases in biological matrices, and the way the compound behaves in chromatography and mass spectrometry. For anyone reading a certificate of analysis, the relevant question is how the presence of a terminal modification was actually established rather than assumed from the label.

This post reviews the chemistry of the two most common terminal modifications, why they are introduced during synthesis, and which analytical measurements provide evidence that the intended cap is present on the material in the vial.

Why termini are modified

In nature, N-terminal acetylation is one of the most prevalent co-translational modifications of eukaryotic proteins, and C-terminal amidation is a characteristic post-translational feature of many secreted peptide hormones and neuropeptides, installed by peptidylglycine alpha-amidating monooxygenase acting on a glycine-extended precursor. Synthetic analogues of these sequences are typically made with the same caps so that the molecule under study matches the characterized native form.

Beyond fidelity to a native sequence, capping removes ionizable groups. A free N-terminal amine (pKa near 8) carries a positive charge at neutral pH, and a free C-terminal carboxylate (pKa near 3) carries a negative charge. Acetylation removes the positive charge, and amidation removes the negative charge. A peptide that is capped at both ends therefore has a net charge determined solely by its side chains, which shifts its isoelectric point and often changes its solubility profile across a pH range. Research has also characterized capped peptides as showing reduced degradation by aminopeptidases and carboxypeptidases in in vitro matrices, which is one reason capping is common in stability-oriented design studies.

How the caps are installed in solid-phase synthesis

The C-terminal amide is determined by the resin choice at the start of Fmoc solid-phase synthesis. Rink amide and Sieber amide linkers release a primary amide upon trifluoroacetic acid cleavage, whereas Wang and 2-chlorotrityl resins release the free acid. The decision is therefore made before the first coupling, and an error at this stage is not recoverable downstream.

N-terminal acetylation is typically performed as a final on-resin step after removal of the last Fmoc group, using acetic anhydride with a tertiary base such as diisopropylethylamine or pyridine. Because it is a terminal capping reaction, it competes with nothing further down the sequence; however, incomplete acetylation leaves a fraction of chains with a free amine. Conversely, unintended acetylation can arise earlier in the synthesis if capping steps used to terminate unreacted chains are carried out between couplings. Those capped deletion sequences are acetylated truncation products and appear as impurities rather than as the target, a distinction that matters when reading impurity profiles.

Mass spectrometry as primary evidence

Mass shifts are the most direct readout. Acetylation replaces an amine hydrogen with an acetyl group and adds 42.0106 Da (monoisotopic, C2H2O). Amidation replaces the C-terminal hydroxyl with an amino group, which changes the mass by approximately negative 0.984 Da (OH, 17.0027, replaced by NH2, 16.0187). A one-dalton difference is small, and it is the reason amidated and free-acid forms are easy to confuse at low resolution.

The practical consequence is that the isotopic envelope of a free-acid peptide overlaps with the amide at the M+1 position. A deamidation product of an amidated peptide, meaning the free-acid form that results from hydrolysis or from using the wrong resin, differs from the target by 0.984 Da, and this is close enough to the natural carbon-13 isotope spacing of 1.003 Da that a low-resolution instrument can mistake one for the other. High-resolution instruments such as Orbitrap and time-of-flight analyzers resolve the monoisotopic masses, and a measured value within a few parts per million of the theoretical amidated mass is meaningful evidence. A reported mass with only unit-level accuracy cannot discriminate between these forms for a peptide of moderate size.

Tandem mass spectrometry provides positional information that intact mass cannot. In collision-induced dissociation spectra, b-ions retain the N-terminus and y-ions retain the C-terminus. An acetylated N-terminus shifts the entire b-series by 42.0106 Da, and the b1 ion is often absent or weak because acetylated b1 ions are not especially stable, so the evidence usually comes from b2 and higher. An amidated C-terminus shifts the y-series by approximately negative 0.984 Da relative to the free acid. Observing both shifted series in the same fragmentation spectrum places the modifications at the termini and excludes, for example, acetylation of a lysine side chain, which would shift internal fragments but leave the b-series offset unchanged. This is the same logic used in peptide mapping to localize modifications, applied to a short sequence.

Chromatographic and spectroscopic corroboration

Reversed-phase HPLC provides supporting rather than definitive evidence. Removing a charged group generally increases retention under acidic mobile phase conditions, since the neutralized terminus contributes less polarity. An acetylated, amidated peptide typically elutes later than its uncapped counterpart of the same sequence, and the shift can be several tenths of a minute or more depending on length and gradient slope. Co-injection with an authenticated reference standard, or with an intentionally prepared uncapped analogue, converts this from a qualitative impression into a documented retention comparison. Retention alone cannot establish identity, but a distinct retention difference between capped and uncapped forms is a useful system-level check that the method is capable of separating the two.

Nuclear magnetic resonance offers direct structural confirmation. The acetyl methyl group gives a sharp three-proton singlet near 2.0 ppm in proton spectra, and its integration relative to a well-resolved sequence signal provides a stoichiometric check on the extent of acetylation. C-terminal amide protons appear as two exchangeable resonances in the 7 ppm region in aqueous-organic solvent systems, though they exchange rapidly in water and are best observed in dimethyl sulfoxide. NMR is less commonly included in routine lot release for short research peptides, but it is the reference approach when the question is structural rather than purely one of mass.

Amino acid analysis and Edman degradation offer a complementary angle. Edman sequencing requires a free N-terminal amine, so an N-acetylated peptide yields no sequence signal at the first cycle. A blocked N-terminus is therefore detectable by the failure of the chemistry, which is consistent with, though not specific to, acetylation, since other N-terminal blocks such as pyroglutamate give the same result.

What this means when reading documentation

A name that includes an acetyl or amide designation implies a specific molecular formula, and the reported mass should agree with that formula rather than with the unmodified sequence. When a certificate of analysis lists an observed mass, it is worth checking which theoretical value it is compared against, how many decimal places are reported, and whether the instrument type is stated. Identity by unit-resolution mass alone leaves open the amide versus free-acid question. Documentation that includes a tandem mass spectrum or a high-resolution mass with a stated error in parts per million supports the terminal assignment more directly.

Terminal modifications also interact with other material attributes discussed elsewhere in this journal: counterion content changes with the number of basic sites available to bind trifluoroacetate or acetate, and net charge influences solubility near the isoelectric point. A capped peptide can therefore differ from its uncapped analogue in more than one measured parameter at once.

In summary, N-terminal acetylation and C-terminal amidation are small covalent changes with several measurable consequences. They are installed by decisions made at the start and end of synthesis, they are distinguished from nearby species by accurate mass and fragmentation behavior, and they are corroborated, rather than proven, by retention shifts and spectroscopic signals. Treating the terminal groups as analytes in their own right, rather than as annotations on a name, clarifies what a given analytical dataset does and does not establish about the material described.